Post on 07-Mar-2018
transcript
Wright, 2008 1
Adult Dermatology:Name That Rash and Lesion
Wendy L. Wright, MS, RN, ARNP, FNP, FAANPAdult/Family Nurse Practitioner
Owner - Wright & Associates Family HealthcareAmherst, NH
Partner – Partners in Healthcare Education, LLC
Objectives
Upon completion of this lecture, the participant will:1. Identify various dermatology conditions found
in adults2. Discuss those dermatology conditions that
require an immediate referral3. Develop an appropriate plan for evaluation,
treatment, and follow-up of the various lesions
Dermatofibroma
Common, benign asymptomatic lesionsMay be slightly itchy; Retract beneath the skin when you try to elevate them1-10 lesions occurring on the extremities; most1 10 lesions occurring on the extremities; most common location is the anterior surface of the lower legEtiology: fibrous reaction to trauma, virus or an insect bite
Multiple lesions: Systemic lupus
Wright, 2008 2
Dermatofibroma
Size: 3 – 10 mm in sizeColor: pink - brownAppearance: may appear slightly scaly and feel hardTreatment:
Generally – nothing needs to be done about these lesionsNot worrisomeBiopsy occasionally warranted if unsure of lesion etiology
Dermatofibroma
Dermatofibroma
Wright, 2008 3
Dermatofibroma
TreatmentMonitorElli ti l i iElliptical excisionShave excisionCryosurgery
Contact Dermatitis: Rhus Dermatitis
Rhus DermatitisPoison ivy, poison oak and poison sumac produce more cases of contact dermatitis than all other contactants combinedOccurs when contact is made between the leaf or internal parts of the roots and stem and the individual
Can occur when individual touches plant or an animal does and then touches human
Eruption can occur within 8 hours of the contact but may take up to 1 week to occur
Clinical Pearls
Poison ivy is not spread by scratchingNo oleoresin is found in the vesicles and therefore, can not be spread by scratchingscratchingLesions will appear where initial contact with plant occurredResin needed to be washed from skin within 15 minutes of exposure to decrease risk of condition
Wright, 2008 4
Clinical Presentation
Clinical presentationCharacteristic linear appearing vesicles are likely to appear firstOften surrounded by erythemay yIntensely itchyLesions often erupt for a period of 1 week and will last for up to 2 weeksMore extensive and widespread presentation can occur with animal exposures or burning of the plants / smoke exposure
Contact Dermatitis
Contact Dermatitis
Wright, 2008 5
Treatment
Cool compresses 15 – 30 minutes three times dailyTopical calamine or caladryl lotionsZanfel (OTC) wash binds urushiol oil andZanfel (OTC) wash – binds urushiol oil and removes from body/blisters
75% decrease in itching and rash within 24 hours per package
Colloidal oatmeal baths (AVEENO) once daily
TreatmentOral antihistamines
May wish to use sedating antihistamines at bedtime
Topical corticosteroidsA id th fAvoid usage on the face
Oral prednisone vs. injectable Kenalog or similar
20 mg two times daily x 7 daysKenalog 40 mg injection (IM)
Follow-up
Monitor for secondary infectionsImpetigo
Staph vs. strepMRSAMRSA
Education:Lesions will decrease over a 2 week periodMay continue to erupt over 48 hours despite steroid administrationNot spreading lesions with rubbing or scratching
Wright, 2008 6
Hot Tub FolliculitisInflammation of the hair follicleCaused by infection which occurs within 8 hours – 5 days of using contaminated hot tub or whirlpoolUnfortunately showering after exposureUnfortunately, showering after exposure provides no protectionPseudomonas is the most common cause of hot tub folliculitisMay also be caused by Staphylococcus, but unusual
MSSA or MRSA
Clinical Presentation
One or more pustules may first appearFever may or may not be present; usually low grade if it does occurMalaise and fatigue may accompany the outbreakPustules may have wide rims of erythema
Hot Tub Folliculitis
Wright, 2008 7
TreatmentCulture of lesions is likely warrantedWhite vinegar wet compresses – 20 minutes on three x daily may provide significant benefitOral Antibiotics
Ciprofloxacin is preferred agent if hot tub folliculitis is suspected due to pseudomonas coverage
Discuss contagiousnessNo evidence that it is spread person - person
Perioral DermatitisOccurs in young women and closely resembles acnePapules and pustules are frequently presentLesions are confined to chin and nasolabial f ldfoldsCan also occur in childrenCause is unknown but is believed to be exacerbated by benzoyl peroxide, tretinoin, alcohol based products and frequent moisturizing
Perioral Dermatitis
Wright, 2008 8
Treatment
Tetracycline creamsTwo times daily x 4 weeks
Erythromycin creamsTwo times daily x 4 weeks
MetrogelTwo times daily x 4 weeksMay not be as effective as above agents
Avoid topical steroidsStop moisturizing
Seborrheic Keratoses
Most common benign skin lesionUnknown originNo potential for malignancyUsually asymptomaticRarely familialMost individuals develop 1 or more of these lesions throughout lifetime
Seborrheic Keratoses
CharacteristicsSmooth surface with tiny round, embedded pearlsM b h d d k dMay be rough, dry and crackedSharply demarcatedAppear stuck on the surfaceVary in size from 2 mm to 3 cmLesions are completely epidermal with no deep tissue penetration
Wright, 2008 9
Seborrheic Keratoses
Seborrheic Keratosis
Can Mimic a Malignant Melanoma
Wright, 2008 10
Seborrheic Keratoses
TreatmentReassuranceLesions are only removed for cosmetic
f bi if th l ipurposes or for a biopsy if pathology is unknownIf removed, shave excisionCryosurgeryMonitor for any increase in size, change in appearance
Acne Vulgaris
EtiologyDisease involving the pilosebaceous unitMost frequent and intense where sebaceous glands are the largestAcne begins when sebum production increasesPropionibacterium acnes proliferates in the sebumP. acnes is a normal skin resident but can cause significant inflammatory lesions when trapped in skin
Acne Vulgaris
Noninflammatory lesionsOpen and closed comedones
Inflammatory lesionsInflammatory lesionsPapules, pustules and nodules (cysts)
Wright, 2008 11
Acne Vulgaris
SymptomsPapular lesions on the face, chest and backWhi h dWhite headsBlack heads
SignsPapular lesionsClosed and open comedones
Closed Comedones
Closed Comedones
Wright, 2008 12
Open Comedones
Cystic Acne
Acne Vulgaris
DiagnosisHistory and physical examination
PlanDiagnostic: None
Wright, 2008 13
Acne VulgarisTherapeutic
Benzoyl Peroxide (2.5%, 5% and 10%)Effective as initial medicationBegin early on in the disease process
TretinoinVery effective agentStart with 0.05% - 0.1% creamReduces and minimizes scarring
Topical AntibioticsInitial medication or can be combined with benzoyl peroxideErygel, clindamycin are most commonly utilized
Acne VulgarisTherapeutic
Oral AntibioticsTetracyclineMinocyclineErythromyciny yCephalosporinsShould only be used when topicals are ineffective or when patient has moderate disease at presentation
OCP’sWomen desiring contraception who also have acne
AccutaneCystic acne or mod-severe disease
Acne VulgarisPlan
Educational6 weeks for improvement to be seenAvoid antibacterial soapsDove soap or similar is recommendedDove soap or similar is recommendedAvoid hatsFoods have not been implicated as a causeCaramel products may worsen situationAvoid picking at the lesionsReview side effects of the medications
Wright, 2008 14
PsoriasisEtiology
1-3% of the population worldwideTransmitted geneticallyDisease is lifelong; often beginning in childhoodCharacterized by chronic, recurrent exacerbations and remissionsStress can precipitate an episodeStrep pharyngitis has been known to precipitate the onset
PsoriasisEtiology
Physically and emotionally disablingErodes self esteem and often forces the patient into a life of concealmentpatient into a life of concealmentMedications can precipitate (Beta blockers, lithium)
PsoriasisSymptoms
Red, scaling papules that coalesce to form round-oval plaquesScale is silvery white and is adherentWhen removed, bleeding occurs (Auspitz’s sign)May begin at a site of a sunburn or surgery
This is called Koebner’s phenomenonElbows, knees, scalp, gluteal cleft, toenails, fingernails
Extensor surfaces
Wright, 2008 15
Psoriasis
SignsErythematous papulesPlaquesNail involvementMay be associated with arthritis
Psoriasis
Guttate Psoriasis
Wright, 2008 16
PsoriasisDiagnosis
History and physical examinationBiopsy if uncertain
PlanPlanDiagnostic: None
PsoriasisTherapeutic
Topical corticosteroidsPulse therapyTwo weeks on/ two weeks offCaution: side effects
DovonexDovonexVitamin D3 analogueWorks by inhibiting epidermal cell proliferationCan be used long-term and is very safeDovonex ointment two times daily x 8 weeksMay see about a 70% improvement
Tar: newer preparations are more pleasantIntralesional steroids
Psoriasis
TherapeuticUltraviolet light BRetinoidsRetinoidsSystemic Treatments
MethotrexatePlaquenilEnbrel
Wright, 2008 17
Psoriasis
PlanEducational
MoisturizeConsider psychological therapyReview the nature of this chronic disease
Skin Tags (Achrochordons)
Very commonly encountered benign lesionsSeen in approximately 25% of men and womenMost common locations: axilla, neck, inguinal regionUsually begin in 2nd decade and peak by the 5th decade of life
Skin Tags (Achrochordons)
AppearanceBegins as a tiny flesh-toned or brown lesionM i t 1 i iMay increase to 1 cm in sizeHallmark: polypoid mass on a long narrow stalkBleeds very easily; particularly because they often get caught on a necklace or clothing
Wright, 2008 18
Diagnosis?Linked with____________?
Skin Tags
Skin Tags (Achrochordons)
TreatmentShave excisionCCryosurgeryElectrocautery
Wright, 2008 19
Case StudyS:TM is a 64-year-old Caucasian male who presents with a painful rash located on his right buttock.
Describes the rash as red and blisteredHas been present x 96 hours and is in for an evaluation because the pain is severe. Pain is “9” on 0 – 10 scale. Has tried oral OTC medications without significant improvement Pain is described as a burning sensation;significant improvement. Pain is described as a burning sensation; deep in his buttock. Denies precipitating factors. Pain began approx 2 days before the rash appeared. Denies fever, chills, new soaps, lotions, changes in medications.
Medications: atorvastatin 40 mg 1 po qhs; amlodipine 5 mg 1 po qhs; loratidine 10mg 1 po qd; aspirin 81 mg 1 po qam; various vitamins
Case StudyAllergies: NKDAPMH: dyslipidemia; hypertension; obesity, allergic rhinitisSocial history: 30 pack year history of i tt ki 10 M hi i tcigarette smoking; none x 10 years; Machinist;
happily married x 40+ years
Case StudyO: T:97.8; P: 94; R:18; BP: 148/90
Skin: p/w/d; approximately 15-20 vesicles located on right buttock overlying an erythematous base; vesicles are clustered but without obvious pattern; no streaking, petecchiae. Few scattered vesicles on posterior aspect of right thigh; no lesions on left buttock or legHips: FROM: no tenderness, erythema, masses
Wright, 2008 20
Case StudyO: PE continued
Back: From: no tenderness, erythema, massesAbdomen: Soft, large; + BS; no masses, tenderness, hsmNeuro: intact including light touch pain vibratory toNeuro: intact including light touch, pain, vibratory to right lower extremity; heel, toe walking intact
+ AllodyniaClothing, light touch, cool object
+ HyperalgesiaPainful stimuli elicited significant pain
Examples of Herpes Zoster
Herpes Zoster
Wright, 2008 21
Acute Herpes Zoster
©© Dr P. Dr P. MarazziMarazzi, Science Photo Library. Image used with permission., Science Photo Library. Image used with permission.
Herpes Zoster
Highly contagious DNA virus which during the varicella infection (primary infection) gains access into the dorsal root gangliaVirus remains dormant for decades and is reactivated when an insult occurs to the individual’s immune system
Examples: HIV, chemotherapy, illness, stress, corticosteroid usage
Incidence and Prevalence
3 million cases of chickenpox yearlyDisease of childhood
600,000 - 1 million cases of herpes zoster each year in the United Statesy
Tends to be more of a disease of agingBy age 80, 20% of us will have zoster at some point in our lifetimeMen = Women
www.niaid.nih.gov/shingles/cq.htm
Wright, 2008 22
Risk Factors Increasing age (50-60 years and beyond)Varicella infection when < 2 years of ageImmunosuppressionStress (controversial)Stress (controversial)TraumaMalignancies
25% of patients with Hodgkin’s will develop zoster1
1Stankus, S. et. Al. Management of Herpes Zoster and Postherpetic Neuralgia. Am Fam Physician 2000;61:2437-44, 2447-8)
Goals of Treatment
Treat acute viral infectionShorten courseReduce lesionsReduce lesions
Treat acute painPrevent complications
Postherpetic neuralgia
Acute Treatment OptionsAntiviral
Goal: Reduce viral reproductionCorticosteroids
Initially postulated that these reduce viral replication; recent studies have not found this to be truebe trueHowever, they do decrease pain
Pain ManagementTopical agentsAnti-inflammatory agentsNarcotics
Postherpetic neuralgia preventionwww.aad.org/pamphlets/herpesZoster.html
Wright, 2008 23
Antiviral Treatment Options
Ideally, want to begin within the first 72 hours of the eruption as benefits may be reduced if started after thatThese medications decrease duration ofThese medications decrease duration of the rash and severity of the pain
Studies vary as to how much these products actually reduce the incidence of post-herpetic neuralgia1Stankus, S. et. Al. Management of Herpes Zoster and Postherpetic Neuralgia. Am Fam Physician 2000;61:2437-44, 2447-8)
Controlled Trials of Antiviral Agents in Herpes Zoster
% of patients with PHN at:
3 months 6 months
Acyclovir vs. Placebo
25% vs. 54% 15% vs. 35%
Valacyclovir vs. Acyclovir
31% vs. 38% 19.9% vs. 25.7%
Famciclovir vs. Placebo
34.9% vs. 49.2% 19.5% vs. 40.3%
Adapted from Johnson RW. J Antimicrob Chemother. 2001;47:1-8.
CorticosteroidsOften utilized despite mixed results in clinical trialsPrednisone, when used with acyclovir, in one study reduced pain associated with herpes
tzosterCorticosteroids are currently recommended for individuals over 50 years of age with HZDosage:
30 mg bid x 7 days; 15 mg bid x 7 days; 7.5 mg bid x 7 days1
1Stankus, S. et. Al. Management of Herpes Zoster and Postherpetic Neuralgia. Am Fam Physician 2000;61:2437-44, 2447-8)
Wright, 2008 24
Pain
Pain associated with herpes zoster can range from mild – severeClinician must tailor pain medication options based upon individual presentationbased upon individual presentation
Pain ManagementTopical Agents
Calamine lotion to lesions 2 – 3x/dayBetadine to lesions qdCapsaicin cream once lesions crusted 3 – 5x/dayT i l lid i 5% t h f 12 h t tiTopical lidocaine 5% patch for 12 hours at a time once lesions are crusted
1Stankus, S. et. Al. Management of Herpes Zoster and Postherpetic Neuralgia. Am Fam Physician 2000;61:2437-44, 2447-8)
Acute Pain Management
Oral AgentsAcetaminophen
Has not been shown to be effective in trials)Ibuprofen or similar
Not likely to be effective with neuropathic painy p p
Nerve BlocksHave been shown to be effective for many individuals with severe pain in some trials; other trials -ineffective
Wright, 2008 25
And…the use of medications such as TCA’s, gabapentin, pregabalin,
oxycodone and tramadol during the acute phase of HZ decrease painacute phase of HZ decrease pain
but also may also reduce the risk of PHN
Follow-up
Monitor for secondary infectionsMonitor for evidence of postherpetic neuralgiagMonitor for adverse impact on quality of life
Bullous PemphigoidBullous pemphigoid is a rare, benign subepidermal rash characterized by bullae formationOrigin is unknownDisease of the elderlyMost cases occur after 60 years of ageNo evidence to support any association with other conditions or diseasesMay be an association with concomitant medication usage
Wright, 2008 26
Bullous Pemphigoid
Clinical ManifestationsBegins with a localized area of erythema which looks similar to hives/urticariaIt hi i d tItching is moderate – severeOver the course of 1 – 3 weeks – area becomes darker red or cyanotic in appearanceResembles – erythema multiformeVesicles and bullae rapidly appear
Bullous Pemphigoid
Clinical ManifestationsMost common locations are:
AbdomenGroinFlexor surfaces of the arms and legsPalms and soles are also affected
Nikolsky’s sign is negative
Bullous Pemphigoid
Clinical ManifestationsMay last 9 weeks – 17 yearsAverage – 2 yearsPeriods of remission will follow exacerbationsAfebrileNo systemic illness
Wright, 2008 27
Bullous Pemphigoid
Diagnosis
History and physical examinationCBC with differential
Eosinophilia will be present in 70%Eosinophilia will be present in 70% or greater of individuals
Biopsy of lesions/skin
TreatmentAtarax or similar for itchingTopical steroids
May be helpful in someOral antibiotics
S f l l ti i ith th f ll i tSuccessful resolution in some with the following agents:TCN or MinocyclineErythromycin
Systemic steroidsImmunosuppressive agents
MTXAzathioprine
Wright, 2008 28
Actinic Keratoses
Common, sun-induced, premalignant lesionsIncidence: Increases with age, light complexioncomplexionCaused by years of sun exposureLesions frequently appear after the summer suggesting that sun exposure may cause lesions to become more active
Actinic KeratosesClinical presentation:
Slightly roughened area that often bleeds when excoriatedBest recognized by palpation than observation when first beginsfirst beginsProgresses to an adherent yellow crustSize: 3-6 mmCommon location: scalp, temples, forehead, handsLesion with drainage suggests degeneration into a malignancy
Actinic Keratosis
Wright, 2008 29
Actinic Keratosis
Keratin may accumulate and transform lesion into a cutaneous horna cutaneous hornFrequently seen on the pinna of the ear
Actinic Keratoses
PrognosisCan spontaneously regress if sun exposure is eliminatedG d i if d d lGood prognosis if treated adequatelySmall percentage transform into a squamous cell carcinoma which can metastasize
60% of all squamous cell carcinomas began as an actinic keratosis
Actinic Keratoses
TreatmentCryosurgery
Preferred methodS i l R lSurgical RemovalTretinoin
0.05% - 0.1% cream applied once daily at bedtimeIf no improvement in 3 – 4 months, treat with cryosurgery
Wright, 2008 30
Actinic Keratoses
Treatment5-fluorouracilTopical chemotherapeutic agents
Example – ActinexExample – ActinexImiquimod (Aldara)
2x weekly x 16 weeksAcid peels
Glycolic acid chemical peelsSunscreen
Follow-up
Continuous monitoring of skin for changes in lesionsMonitor for new lesionsSunscreen is essentialSunscreen is essentialMinimize sun exposure
Basal Cell Carcinoma
Most common cutaneous malignancy found in humansPresenting complaint: bleeding or scabbing sore that heals and recurssore that heals and recursRisk factors: fair skin, sun exposure, tanning salon, previous injuryIncidence: Men > women: Incidence increases after age 40
Wright, 2008 31
Basal Cell Carcinoma
Location: 85% appear on the head and neck; 25-30% on the nose alonePrognosis: Excellent because basal cell carcinomas rarely metastasize but willcarcinomas rarely metastasize but will grow and spread to adjacent locationsVery common for a 2nd or 3rd basal cell to appear
Basal Cell CarcinomaSix Clinical Types:
Nodular (21%): rounded massMost common formPearly white or pinkT l i t ti l tTelangiectatic vessels are presentUlcerating center is commonMay present as a nonhealing lesion
Superficial (17%): Least aggressive lesionPigmented: May resemble a melanoma
Basal Cell CarcinomaSix Clinical Types:
Cystic: Similar to nodular lesionSclerosing: Borders indistinct
May grow for years before recognizedMay grow for years before recognizedMay resemble a scar – depressed lesion
Nevoid: very rare; inherited as an autosomal dominant trait; Multiple BCC’s appear at birth
Wright, 2008 32
Basal Cell Carcinoma
Basal Cell Carcinoma
Basal Cell Carcinoma
TreatmentElectrodessicationExcisionCryosurgeryMohs’ micrographic surgeryRadiationImiquimod (superficial basal cells)
Wright, 2008 33
Squamous Cell Carcinoma
Arises in the epithelium and is common in middle-aged to elderly population2 types
Areas of prior radiation or thermal injury and in chronic ulcers: most likely to metastasizeActinically damaged skin: Least likely to metastasize
Squamous Cell Carcinoma
Risk factorsSun exposureRenal transplant recipients (253 fold increase secondary to immunosuppression)increase secondary to immunosuppression)Areas of chronic inflammation or thermal burns
LocationSun exposed regions: scalp, back of the hands, and superior aspect of the pinna
Squamous Cell Carcinoma
Clinical PresentationMay arise from previous actinic keratosisThick, adherent scale with a red, inflamed baseFirm, movable, elevated lesion with a sharply defined borderCan spread locally and metastasize
Wright, 2008 34
Squamous Cell Carcinoma
Squamous Cell Carcinoma
Squamous Cell Carcinoma
TreatmentReferral to dermatology or plastics depending upon location / availabilityp g p yElectrodessicationExcision with margins
Wright, 2008 35
Malignant Melanoma
Very dangerous cancer that arises from the cells of the melanocytic systemCan metastasize to any organ including the brainEpidemic proportions - Lifetime risk: 1:90Risk factors
Sun exposureFamily history of melanomaImmunosuppression
Malignant Melanoma
ABCDE’s of Malignant MelanomaAsymmetryBordersColorDiameter enlargementEnlarging or evolving
Malignant Melanoma
CharacteristicsCan be black, brown, red, white or blue
TypesypSuperficial spreadingLentigo malignaNodular melanomaAcrallentiginous melanoma
Wright, 2008 36
Malignant Melanoma
Malignant Melanoma
Malignant Melanoma
TreatmentBiopsy with elliptical excision onlyShave excision and punch biopsy are NOT recommendedReferral to dermatology/general surgeon/plastics depending upon accessSurgical excision with margin clearing
1-2 cm marginRecent evidence that a 3 cm margin may improve survival rates
Wright, 2008 37
Thank You!
I Would Be Happy To Entertain Any
Questions
Wendy L. Wright, MS, RN, ARNP, FNP, FAANP
Partners in Healthcare Education, LLCwww.4healtheducation.com